Company Filing History:
Years Active: 1994-1997
Title: The Innovations of Jeffrey William Almond
Introduction
Jeffrey William Almond is a notable inventor based in Reading, GB. He has made significant contributions to the field of vaccine development, particularly in the area of poliovirus research. With a total of 4 patents to his name, Almond's work has had a profound impact on public health.
Latest Patents
Almond's latest patents include groundbreaking innovations such as an attenuated poliovirus vaccine and methods for vaccination. One of his patents describes an attenuated poliovirus in which the 5' non-coding region of the genome is modified. Another patent focuses on attenuated viruses, specifically an enterovirus or rhinovirus that is suitable for use as a vaccine. This invention features a reversed base pairing in the 5' non-coding region of the genome of poliovirus type 3 Leon strain, with specific bases identified at critical positions for effective vaccine development.
Career Highlights
Throughout his career, Jeffrey William Almond has been associated with British Technology Group Limited, where he has furthered his research and development efforts. His work has been instrumental in advancing vaccine technology and improving immunization strategies.
Collaborations
Almond has collaborated with esteemed colleagues in the field, including Philip D Minor and Michael A Skinner. These partnerships have enhanced the scope and impact of his research, leading to innovative solutions in vaccine development.
Conclusion
Jeffrey William Almond's contributions to vaccine research and development are noteworthy and continue to influence the field. His innovative patents and collaborations reflect his commitment to improving public health through scientific advancements.